Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”

• Young Eun Chon,
• Dong Yun Kim,
• Hong Jae Chon,
• Do Young Kim

Affiliations

Young Eun Chon

Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea

Dong Yun Kim

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

Hong Jae Chon

Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea

Do Young Kim

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea